Inventor
BOYD STEVEN A
US33 patents
⚠️ This page may combine multiple inventors who share the name “BOYD STEVEN A”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ABBOTT LAB
15 patentsUS6579882B2Jun 17, 2003
Cell adhesion-inhibiting antiinflammatory compounds
ABBOTT LAB189 citations97
US6232320B1May 15, 2001
Cell adhesion-inhibiting antiinflammatory compounds
ABBOTT LAB234 citations97
US6162927ADec 19, 2000
Endothelin antagonists
ABBOTT LAB46 citations96
US5767144AJun 16, 1998
Endothelin antagonists
ABBOTT LAB90 citations96
US7365093B2Apr 29, 2008
Endothelin antagonists
ABBOTT LAB18 citations92
US6946481B1Sep 20, 2005
Endothelin antagonists
ABBOTT LAB37 citations92
US6462194B1Oct 8, 2002
Endothelin antagonists
ABBOTT LAB14 citations92
US6124341ASep 26, 2000
Endothelin antagonists
ABBOTT LAB21 citations92
US5622971AApr 22, 1997
Endothelin antagonists
ABBOTT LAB25 citations92
US6878700B1Apr 12, 2005
Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
ABBOTT LAB14 citations83
US6380241B1Apr 30, 2002
Treatment of diseases using endothelin antagonists
ABBOTT LAB13 citations82
US5731434AMar 24, 1998
Endothelin antagonists
ABBOTT LAB15 citations82
US5244910ASep 14, 1993
Renin inhibitors
ABBOTT LAB8 citations73
US5268374ADec 7, 1993
Non-peptide renin inhibitors
ABBOTT LAB8 citations72
US5389647AFeb 14, 1995
Renin inhibitors
ABBOTT LAB4 citations62
VENATORX PHARMACEUTICALS INC
13 patentsUS11638715B2May 2, 2023
Orally-bioavailable nucleoside analogs
VENATORX PHARMACEUTICALS INC9 citations84
US10399996B2Sep 3, 2019
Beta-lactamase inhibitors
VENATORX PHARMACEUTICALS INC6 citations84
US10590076B2Mar 17, 2020
Hepatitis B capsid assembly modulators
VENATORX PHARMACEUTICALS INC6 citations82
US10464952B2Nov 5, 2019
Beta-lactamase inhibitors
VENATORX PHARMACEUTICALS INC5 citations72
US11566001B2Jan 31, 2023
Hepatitis B capsid assembly modulators
VENATORX PHARMACEUTICALS INC2 citations71
US11267826B2Mar 8, 2022
Penicillin-binding protein inhibitors
VENATORX PHARMACEUTICALS INC2 citations62
US11046716B2Jun 29, 2021
Beta-lactamase inhibitors
VENATORX PHARMACEUTICALS INC1 citations62
US12102648B2Oct 1, 2024
Orally-bioavailable nucleoside analogs
VENATORX PHARMACEUTICALS INC0 citations61
US11247965B2Feb 15, 2022
Hepatitis B capsid assembly modulators
VENATORX PHARMACEUTICALS INC1 citations61
US11014881B2May 25, 2021
Hepatitis B capsid assembly modulators
VENATORX PHARMACEUTICALS INC1 citations60
US12084445B2Sep 10, 2024
Broad-spectrum carbapenems
VENATORX PHARMACEUTICALS INC0 citations51
US12173018B2Dec 24, 2024
Penicillin-binding protein inhibitors
VENATORX PHARMACEUTICALS INC0 citations50
US11332485B2May 17, 2022
Penicillin-binding protein inhibitors
VENATORX PHARMACEUTICALS INC0 citations50
KNOPP BIOSCIENCES LLC
3 patentsUS9914708B2Mar 13, 2018
Benzoimidazol-1,2-yl amides as Kv7 channel activators
KNOPP BIOSCIENCES LLC10 citations92
US9481653B2Nov 1, 2016
Benzoimidazol-1,2-yl amides as Kv7 channel activators
KNOPP BIOSCIENCES LLC15 citations92
US9650376B2May 16, 2017
Imidazo(4,5-B) pyridin-2-yl amides as KV7 channel activators
KNOPP BIOSCIENCES LLC8 citations81